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Abstract In this study, we aimed to prepare a neovascu-
larization-relevant inflammatory cytokine-targeted ultra-
sound contrast agent and apply it in the ultrasound imaging of
atherosclerotic plaque. An interleukin-8 (IL-8) monoclonal
antibody was conjugated to SonoVue microbubbles using the
N-succinimidyl-3-(2-pyridyldithio)propionate cross-linking
method. Then, a prepared IL-8-targeted contrast agent was
used for contrast-enhanced ultrasound (CEU) to detect rabbit
abdominal aorta atherosclerotic plaque and to investigate the
imaging characteristics of atherosclerotic plaque with the
contrast agent. We found that an IL-8 monoclonal antibody
can be successfully coupled to SonoVue microbubbles with
stable biological characteristics. CEU with this IL-8-targeted
contrast agent can increase the atherosclerotic plaque detec-
tion sensitivity, with stronger echo, so that three more plaques
were detected compared with using non-targeted SonoVue
microbubbles. Thus, an inflammatory cytokine-targeting
ultrasound contrast agent carrying IL-8 monoclonal antibody
can provide unique advantages for researching the charac-
teristics of atherosclerotic plaque.
Keywords Contrast-enhanced sonography  IL-8 
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Introduction
Atherosclerosis is a common ischemic cardiovascular and
cerebrovascular disease. Atherosclerotic progression
eventually leads to the occurrence of severe cardiovascular
events, such as myocardial infarction or stroke. As the
prevalence of atherosclerosis increases globally due to an
aging population, identifying atherosclerotic plaques will
be important for early diagnosis and intervention, which
will substantially decrease the healthcare burden.
Current non-invasive imaging modalities for athero-
sclerotic plaque detection include ultrasound, computed
tomography (CT), magnetic resonance imaging (MRI), and
angiography [17]. With the improvement of contrast-
enhanced sonography techniques and the development of
targeted contrast agents, microbubble contrast agents for
ultrasound have emerged as a widely used tool that holds
great potential in targeted contrast ultrasound imaging
investigations [21].
Atherosclerosis occurs because of chronic injury to the
endothelium, and angiogenesis is the most important
pathological feature of atherosclerosis [12]. Ultrasound
contrast microbubbles can clearly show the adventitia that
nourishes atherosclerotic vessels as well as intraplaque
neovascularization [4]. Previous studies of targeted imag-
ing of atherosclerotic plaque have mainly focused on vas-
cular endothelial growth factor receptor-2 [9], intercellular
adhesion molecule-1(ICAM-1) [18, 19], vascular cell
adhesion molecule-1 (VCAM-1), P-selectin [5], and oxi-
dized low-density lipoprotein (OxLDL) [16]. While inter-
leukin-8 (IL-8) is a key vasculogenesis regulator in
atherosclerotic lesions and is capable of promoting angio-
genesis and plaque formation, increasing evidence suggests
that IL-8 is highly expressed within human atheroscle-
rotic lesions ([2]; [14]).
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Therefore, in the current study, acoustic contrast agents
targeted to IL-8 were prepared and used for abdominal
aortic plaque detection in a rabbit atherosclerosis model.
We aimed to investigate the value of inflammatory factor-




A solution of sulfur hexafluoride microbubbles (SonoVue,
Bracco, Milan, Italy) was prepared with an average
microbubble diameter of 2.5 lm and concentration of
17 mg/mL. Then, the microbubbles were conjugated to the
antibodies by means of N-succinimidyl-3-(2-pyridyldi-
thio)propionate (SPDP) conjugation. Briefly, mouse anti-
human IL-8 monoclonal antibody (Bender MedSystems,
Vienna, Austria) was dissolved in 0.01 mol/L PBS (pH 7.4)
solution, followed by addition of a 20 mmol/L SPDP
(Merck, Darmstadt, Germany) solution to a ratio of 1:15.
The mixture was incubated for 60 min at 4 C to react, and
it then underwent five cycles of 8 min of centrifugation at
6,500 rpm followed by filtration through Microcon YM-30
filters (Millipore, Bedford, MA, USA) to remove the
unbound SPDP.
Excess dithiothreitol (DTT, Invitrogen, Carlsbad, Cali-
fornia, USA) dissolved in acetic acid was added to the
solution of monoclonal antibodies containing pyridine
disulfide groups (McAb-PDP) before incubation for 30 min
at 4 C. This mixture was then centrifuged for 8 min at
6,500 rpm and filtered three times through Microcon filters
to remove unbound DTT, and the IL-8 monoclonal antibody
solution with sulfhydryl (McAb-PDP-SH) was obtained.
The SonoVue microbubble suspension was reacted with
20 mmol/L SPDP solution at 4 C for 60 min. The reaction
solution was washed with 0.01 mol/L PBS (pH 7.4) using
the floating method [8] to produce a microbubble suspen-
sion with pyridine disulfide groups. This suspension was
immediately mixed with the McAb-PDP-SH solution and
left to react at 4 C overnight. The IL-8 monoclonal anti-
body-conjugated acoustic microbubble suspension was
obtained after a final wash with PBS.
Characterization of targeted microbubbles
Targeted SonoVue microbubble morphology
The IL-8 monoclonal antibody-conjugated SonoVue
microbubble suspension and non-conjugated SonoVue
microbubble suspension were smeared onto glass slides
and observed under a microscope (Nikon Eclipse E200,
Tokyo, Japan) to examine the structural properties, size,
shape, and concentration of the microbubbles.
Slide agglutination test
The IL-8 monoclonal antibody-conjugated SonoVue micro-
bubble suspension was mixed with either goat anti-mouse
IgG serum (KPL Laboratories, Gaithersburg, MD, USA) or
saline. The non-conjugated SonoVue microbubble suspen-
sion was mixed with either goat anti-mouse IgG or saline.
These four mixtures were smeared onto clean slides and
observed under a microscope to examine the morphology,
structural properties, and other characteristics of the micro-
bubbles [20].
Immunofluorescent staining
Microbubbles conjugated with IL-8 antibody were added to
PBS for oscillation, and the supernatant bubbles were dec-
anted to another PBS solution for further shaking. This
process was repeated 3 times. Impurities and non-conjugated
IL-8 antibody remained at the bottom, while microbubbles
floated to the surface. Thus the conjugated microbubbles
were successfully separated. Samples of microbubbles were
microscopically observed after each oscillation and washing
to ensure that their nature (aggregation state of microbub-
bles, as in Fig. 1) was unchanged.
The non-conjugated microbubbles and IL-8-conjugated
microbubbles were smeared on clean glass slides, and
1:100 FITC sheep anti-mouse IgG antibody (Merck,
Darmstadt, Germany) was added following incubation at
4 C for 60 min. Fluorescence microscopy was used to
observe the fluorescent staining.
Animal models and preparation
The animal experiments were approved by the institutional
Animal Research Committee. Seventeen male Japanese
white rabbits (1 month old) were used to establish a model of
atherosclerosis of the abdominal aorta. Rabbits were fed a
high-fat diet containing 1 % cholesterol, 7.5 % egg yolk
powder, 8 % beef fat, and 83.5 % normal diet by weight, and
they had free access to water. After 12 weeks of feeding,
high-frequency ultrasound was performed to detect the for-
mation of plaque within the abdominal aorta [15].
In vivo targeted imaging of atheromatous abdominal
aortas of rabbits
The auricular vein was cannulated, and the rabbits were
anesthetized with intravenous sodium pentobarbital. Ultra-
sound imaging (Philips iE33 Ultrasound, Philips Medical
Systems, Andover, MA, USA) of the aorta was performed
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with an L9-3 probe at a high-frequency of 7 MHz. The frame
rate of CEU was 50 Hz with temporal resolution of 17.5 ms.
The mechanical index was 0.08, and the dynamic range was
50 dB. All settings were kept constant during the experiment.
Stable images of the abdominal aorta were obtained by
scanning from the sub-xiphoid. CEU was started when
atherosclerotic plaque was clearly seen with high-frequency
ultrasound. CEU was first performed with the non-targeted
SonoVue microbubble and then with the IL-8-targeted So-
noVue microbubble 15 min later. The microbubbles
(0.05 mL/kg) were quickly injected via the auricular vein,
followed by infusion of 1 mL saline to flush the duct. Once
contrast agent was injected, the CEU program was started to
acquire continuous dynamic images for 3 min post-injection.
Image data were analyzed offline using QLAB software
(Philips Medical Systems, Bothell, WA, USA). A region of
interest with the same size and location of the plaque was
placed in the frame, and another area of 1.5 9 1.5 mm was
placed in the adjacent arterial lumen and intima as the control
region. Subsequently, a time-intensity curve (TIC) was plot-
ted and used to calculate the characteristic parameters with
the equation (t) = A*t* exp (-Alpha *t) ? C, where A is the
upslope rate, Alpha is the downslope rate, C is the initial time,
and t is the initial time of ascending. The parameters mea-
sured with TICs were echo mean, peak intensity, wash-in
time, time to peak, and time from peak to one-half.
Histology and immunochemistry
The animals were humanely sacrificed after ultrasound
imaging, and the abdominal aorta was excised for frozen
section preparation and HE staining. The luminal surface was
observed by microscopy (Nikon Eclipse E200, Tokyo, Japan).
To measure IL-8 expression in the plaques of the
abdominal aorta, immunochemistry for IL-8 was per-
formed. After deparaffinization and hydration, the paraffin
sections were washed with tap water. After the addition of
rabbit polyclonal antibody against IL-8 (Bioss, Beijing,
China), the sections were incubated at room temperature
for 60 min, washed with PBS, and stained using a Max-
visionTM2 HRP-Polymer anti-Mouse IHC Kit (Maxim
Biotech Inc. Fuzhou, China). The sections were counter-
stained with hematoxylin and mounted.
To validate the neovascularization in the plaques of the
abdominal aorta, immunohistochemistry was performed to
detect CD34 expression. The plaques in the rabbit
abdominal aortas were taken for paraffin sections. After
dehydration, endogenous peroxidase was blocked, and the
slides were pre-incubated with 1 % bovine serum albumin/
PBS solution. Mouse monoclonal anti-CD34 antibody
(Maxim Biotech Inc.) was added, the sections were incu-
bated overnight at 4 C, and they were stained using an
immunohistochemical streptavidin peroxidase (SP) kit
(Maxim Biotech Inc.). After color development with DAB
chromogen, the sections were counterstained with hema-
toxylin and mounted for observation under a light micro-
scope. The dense brown masses (CD34-positive staining)
indicated a dense microvessel.
Statistical analysis
All experimental data are reported as the mean ± SD and
wereanalyzedusing SPSS 13.0 (SPSS Inc,Chicago, IL, USA).
A paired t test was performed to compare the differences
between the control and targeted imaging groups. Findings
with P \ 0.05 were considered statistically significant.
Results
Morphology of microbubble conjugation
The concentration of the microbubble suspension was
17 mg/ml. The non-conjugated microbubbles had a uniform
Fig. 1 Light micrograph of SonoVue microbubbles. a Non-conjugated SonoVue microbubbles. b IL-8 monoclonal antibody-conjugated
SonoVue microbubbles (9100)
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size with a diameter of 2–4 lm, and the distribution was also
uniform with a single and scattered pattern (Fig. 1a).
Whereas the IL-8 monoclonal antibody-conjugated Sono-
Vue microbubbles had relatively low densities, the size,
shape and structural properties of the microbubbles were
similar to those of non-conjugated microbubbles, as they had
a uniform size and distribution (Fig. 1b).
Slide agglutination test
The non-conjugated SonoVue microbubbles did not present
agglutination when mixed with goat anti-mouse serum, as
their size and scattering were uniform (Fig. 2a). Two types of
microbubbles did not show any obvious changes in bubble
size, shape or macrostructural properties in the presence of
normal saline, again indicating no agglutination. When goat
anti-mouse serum was added, the IL-8 monoclonal antibody-
conjugated SonoVue microbubbles agglutinated readily,
with several microbubbles gathered in string-like clusters but
no longer scatted (Fig. 2b, c), indicating that IL-8 mono-
clonal antibodies had been successfully conjugated to the
shell surface of the microbubbles.
Immunofluorescent staining of the microbubbles
When mixed with sheep anti-mouse–FITC, no fluorescence
was observed on the surface of uncoupled SonoVue
microbubbles with a fluorescence microscope, whereas
there was obvious green fluorescence from IL-8 antibody-
conjugated bubbles (Fig. 3).
In vivo ultrasound imaging of plaques
After high-fat diet feeding, 19 plaques were detected using
two-dimensional ultrasound examination in 17 rabbits, with
soft plaques dominating. Plaques were visualized as hypo-
echoic in six lesions, isoechoic in seven lesions, and hyper-
echoic in six lesions. Thirteen plaques occurred at the
abdominal aortic bifurcation, and six were located at other
sites. CEU with normal SonoVue microbubbles identified an
additional three plaques. With IL-8-targeted microbubbles,
CEU detected two new hypoechoic plaques that were missed
by normal CEU (Fig. 4).
During the contrast ultrasound imaging of abdominal aortas
with normal or IL-8-targeted microbubbles, contrast was
Fig. 2 Light micrograph of the mixture of SonoVue microbubbles
and goat anti-mouse serum. a Non-conjugated microbubbles (9100).
b Non-conjugated microbubbles (9400). c IL-8 monoclonal antibody-
conjugated microbubbles (9100). d IL-8 monoclonal antibody-
conjugated microbubbles (9400)
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initially observed in the vessel lumen, and then it gradually
filled the adventitia and the whole plaque. The vasa vaso-
rum was strongly contrasted as well. Generally, the con-
trast could be visualized in the lumen 3–6 s after the
injection of contrast agent, in the intima at 4–8 s, and in the
atherosclerotic plaque at 5–10 s.
However, contrast imaging with IL-8-targeted micro-
bubbles provided enhanced echo intensity of atheroscle-
rotic plaques compared to the normal contrast imaging.
Detailed information of the surrounding vasa vasorum was
also clearer. Briefly, the contrast gradually increased from
the intima and wall of the lumen to plaque in a sparse and
spot-like pattern, and it connected with the capillary ves-
sels that originated from the intima on the edge of the
plaque lesions. These signs were even more pronounced for
hypoechoic plaques (Fig. 5).
Time-intensity analysis
The time-intensity curves based on the normal and IL-8-
targeted ultrasound imaging presented similar trends for
the contrast of the lumen, intima and atherosclerotic pla-
ques. The peak intensity was followed by a fast ascending
phase after injection of the contrast agents, and a slow
descending phase occurred after the peak intensity pulse
(Fig. 6). The contrast enhancement was observed in the
lumen 3–6 s after injection, 4–8 s in the intima with a
gradually higher echo, and 5–10 s in the atherosclerotic
plaque.
The time-intensity data using the targeted and the non-
targeted contrast agent are compared in Table 1. In the
lumen, there were no significant difference in wash-in time,
time to peak or time from peak to one-half between contrast
Fig. 3 Immunofluorescence image of IgG-FITC-stained SonoVue
microbubbles. a No fluorescence was observed on the surface of non-
conjugated SonoVue microbubbles. b Bright-green fluorescence can
be observed on the surface of IL-8-conjugated SonoVue microbubbles
(9400). (Color figure online)
Fig. 4 Representative ultrasound images of the atherosclerotic
plaques in the rabbit abdominal aorta. a Two-dimensional image
showing a plaque (large arrow); a soft plaque was invisible (small
arrow). b Contrast ultrasound imaging with normal microbubbles
showing two plaques with stronger echo compared with the two-
dimensional view. The enhancement of the echo was more apparent
for the soft plaque (small arrow). c Contrast ultrasound imaging with
IL-8-targeted microbubbles showing two plaques with a markedly
stronger echo compared with normal contrast ultrasound
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ultrasound imaging with normal microbubbles and IL-8-
targeted microbubbles. The comparison also presented no
significant difference in intraluminal echo mean or peak
intensity. The common contrast characteristics of IL-8-tar-
geted microbubbles and non-targeted microbubbles in the
lumen indicated that the prepared IL-8-targeted SonoVue
microbubbles are physically stable.
For the intima and the plaque, the echo mean and peak
intensity in targeted imaging were significantly increased
compared with normal CEU (P \ 0.05), indicating that
IL-8-targeted SonoVue microbubbles can enhance the
echoes of the intima and plaque. In addition, plaques under
targeted imaging were easier to identify because both the
intima/lumen ratio and plaque/lumen ratio were increased
compared to normal CEU (P \ 0.05). Wash-in time and
time to peak demonstrated no difference between condi-
tions, suggesting that the mechanism by which contrast
improved in the intima and plaques is the same for the two
contrast agents. The time from peak to one-half was sig-
nificantly prolonged with targeted imaging (P \ 0.05),
revealing an extended combination of contrast agent with
intima and plaque, which facilitated the detection of
plaques.
Histology and immunochemistry
All atherosclerotic plaques of the abdominal aorta detected
with contrast imaging were confirmed with histological
examination. Fig. 7 shows histological images of athero-
sclerotic plaque specimens. The intima was markedly
thickened. The atherosclerotic plaques consisted of large
numbers of foam cells, which were widely distributed in
the media and subintimal region. Smooth muscle cell
proliferation, with a disorganized arrangement, was
observed in the media layer.
Immunohistochemical examination of IL-8 expression
in atherosclerotic plaques showed a mass of brown (posi-
tive) substance at the basal and inner parts of the athero-
sclerotic plaques, indicating the high expression of IL-8 in
rabbit abdominal aortas (Fig. 8).
Finally, we investigated neovascularization in the ath-
erosclerotic plaques in the rabbit abdominal aorta. The
plaques identified by contrast imaging showed strong
brown staining (CD34) in the inner part and base of the
plaque compared with adjacent healthy intima (Fig. 9).
This indicates a high neovascular density in the plaques,
which is consistent with enrichment of the targeted
microbubbles in contrast imaging.
Discussion
Currently, ultrasound contrast imaging is of intense interest
in the field of atherosclerotic plaque detection. Acoustic
microbubbles are a type of intravascular contrast agent that
can be conjugated with targeted ligands to bind to lesions
with high specificity and high affinity [6, 18, 19]. In this
study, an IL-8 monoclonal antibody was conjugated to the
liposome contrast agent SonoVue via an active targeting
approach, and the prepared IL-8-targeted contrast agent
Fig. 5 Sequential ultrasound images of IL-8-targeted imaging for an
atherosclerotic plaque of the rabbit abdominal aorta. a Conventional
two-dimensional view. b–g Sequential targeted CEU view: b 3.8 s
post-contrast agent injection, c: 4.3 s post-contrast agent injection,
d 4.9 s post-contrast agent injection; e 9.8 s post-contrast agent
injection, f 68 s post-contrast agent injection, g 176 s post-contrast
agent injection
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Fig. 6 The time-intensity curves of contrast ultrasound imaging with normal microbubbles (a) and IL-8-targeted microbubbles (b). The yellow,
blue and red curves indicate the intensity of the lumen, intima and plaques, respectively. (Color figure online)











Non-targeted UCA (N = 22) Lumen 4.4 ± 1.9 12.3 ± 4.9 3.5 ± 2.3 15.3 ± 3.9 29.7 ± 6.3
Intima 3.5 ± 1.6 12.7 ± 5.6 6.1 ± 2.2 18.2 ± 4.0 35.0 ± 5.9
Intima/lumen ratio 0.79 ± 0.21 1.01 ± 0.23 1.4 ± 0.55 1.15 ± 0.45 1.18 ± 0.48
Plaque 4.2 ± 2.1 15.4 ± 5.4 7.2 ± 2.4 18.5 ± 4.3 38.5 ± 5.6
Plaque/lumen ratio 0.95 ± 0.23 1.23 ± 0.34 1.98 ± 0.55 1.2 ± 0.53 1.29 ± 0.49
Targeted UCA (N = 24) Lumen 4.6 ± 2.5 12.5 ± 6.7 3.7 ± 2.9 15.9 ± 4.9 30.2 ± 6.8
Intima 5.5 ± 1.6* 16.3 ± 7.2* 5.5 ± 2.6 18.2 ± 5.2 43.8 ± 7.8*
Intima/lumen ratio 1.20 ± 0.28* 1.31 ± 0.33* 1.4 ± 0.48 1.14 ± 0.51 1.41 ± 0.53*
Plaque 6.8 ± 1.8* 18.7 ± 5.9* 6.9 ± 2.8 20.5 ± 5.6 46.7 ± 7.9*
Plaque/lumen ratio 1.47 ± 0.36* 1.50 ± 0.37* 1.9 ± 0.49 1.2 ± 0.57 1.53 ± 0.47*
UCA ultrasound contrast agent
*Significant difference between targeted and non-targeted UCA (P \ 0.05). Values are provided as the mean ± SD
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was successfully applied to ultrasound imaging of rabbit
abdominal aorta atherosclerotic plaque and showed
increased detection sensitivity compared with non-targeted
SonoVue microbubbles.
The development of targeted ultrasound contrast agents is
still in the nascent phase. Several studies have shown that
covalent coupling is an ideal method to conjugate specific
antibodies to the surface of the acoustic microbubble, and this
Fig. 7 Typical histological images of rabbit abdominal aortic atherosclerotic plaque (a9100, b9400)
Fig. 8 Immunohistochemical expression of IL-8 in atherosclerotic plaques in the rabbit abdominal aorta. Brown-stained area indicates positive
IL-8 expression. (a 940; b 9200). (Color figure online)
Fig. 9 The missed soft plaque in two-dimensional images was
identified by CD34 immunohistochemistry by its greatly increased
brown staining (CD34-positive) in the inner part and base of the
plaque compared with adjacent healthy intima. This result indicates a
high neovascular density for the plaque, which is consistent with
enrichment of the targeted microbubbles in contrast imaging. (a 940;
b 9100). (Color figure online)
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method has been successfully used to develop antibody-
conjugated liposome microbubbles [3, 20]. SonoVue is a
widely used blood pool ultrasound contrast agent. In the
present study, IL-8 monoclonal antibody was covalently
linked to the liposome shell of the SonoVue microbubble via a
disulfide bond using the SPDP method, and the size, shape,
and macrostructural properties of the microbubbles were
stable. This result indicates that the physical and biological
characteristics of the microbubbles can be kept constant after
SPDP cross-linking; therefore, the IL-8-conjugated SonoVue
microbubbles can be safely applied in vivo. In addition, goat
anti-mouse IgG serum agglutinates with mouse anti-human
IL-8 monoclonal antibody if the primary antibody (in this case
the IL-8 monoclonal antibody) exists in the microbubble
compound. Our slide agglutination test revealed extensive
agglutination when the IL-8 monoclonal antibody-targeted
acoustic microbubble suspension was mixed with goat anti-
mouse IgG. Immunofluorescent staining showed that only IL-
8 antibody-conjugated microbubbles presented fluorescence
when mixed with sheep anti-mouse IgG-FITC. Both of these
results indicate that an IL-8 monoclonal antibody has been
successfully coupled to the shell surface of the microbubbles.
These characterizations of the targeted microbubbles dem-
onstrate that the specific contrast agent, namely IL-8-conju-
gated SonoVue microbubbles, can be successfully developed
via the SPDP method.
Due to the increasing trend of cardiovascular and cere-
brovascular events in many patient populations, the iden-
tification and analysis of atherosclerotic plaque are of
utmost importance for the reduction of these severe events.
Neovascularization-relevant inflammation, as well as the
inflammatory factors involved in this process, are consid-
ered indicators of the stability of the atherosclerotic plaque
and are therefore the focus of intense investigation [10].
IL-8 is the representative factor of the chemokine CXC
group. It is mainly secreted by monocyte-macrophages at
the lesion site, with high expression at sites of human
atherosclerotic plaque [7]. It is the main chemokine that
continually induces immune cells to invade atherosclerotic
plaques. IL-8 is an important angiogenic factor at plaque
lesion sites, promoting the formation and progression of
atherosclerotic plaques. It is worth noting that IL-8 is one
of the inflammatory factors secreted by macrophages,
monocytes and endothelial cells, suggesting that angio-
genesis is associated with inflammatory reactions [13].
In this study, we initially applied an IL-8 monoclonal
antibody-targeted acoustic contrast agent to access the
atherosclerotic plaques in the rabbit abdominal aorta. We
found that the contrast curves for the lumen, intima and
plaque in the presence of targeted and non-targeted contrast
agents shared similar trends. Moreover, targeted CEU with
IL-8 antibody-conjugated microbubbles enabled us to
observe the blood-supply characteristics of atherosclerotic
plaques in more detail, i.e. the feeding vessels of the pla-
ques. These blood-supply features are closely related to the
stability of the plaque [11, 22]. Because new intraplaque
vessels primarily originate from preexisting capillaries in
the vascular wall by budding or non-budding mechanisms,
the periphery of the plaque usually presents with denser
capillaries and inflammatory cells and more severe
inflammatory reactions, Hence, it is easier to induce angi-
ogenesis at the plaque periphery than in central regions. As
a result, the aforementioned contrast characteristics will be
more prevalent for unstable plaques. The relationship
between the plaque stability and the targeted CEU features
will be further investigated along with pathological fea-
tures in our future studies.
A limitation of ultrasound is that B-mode imaging is a
qualitative and semi-quantitative technique, which is
mainly used to subjectively observe the perfusion trend in
the plaques during contrast imaging. In our study, B-mode
imaging provided a preliminary basis for the quantitative
analysis with QLAB software before further observation of
the targeted microbubble binding.
In summary, a novel ultrasound contrast agent, IL-8-
targeted SonoVue microbubbles, was successfully devel-
oped and used to detect atherosclerotic plaques in the rabbit
abdominal aorta. CEU with the agent can effectively
identify atherosclerotic plaques in vivo, including those
plaques not detected with non-targeted CEU imaging. This
method may become a valuable imaging technique for
diagnosing atherosclerotic lesions in clinical practice.
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